01332 TOUYUN BIOTECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.17X | Oper Margin | 114.7% |
|---|---|---|---|
| LT Debt/Equity | N/A | Net Margin | 37.3% |
| Total Debt/Equity | N/A | Return on Equity | 52.5% |
| Price/Book | N/A | Return on Assets | 4.3% |
| (HKD 0.166) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 26.80 | -88.11 | -268.94 | -198.07 | -72.95 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +130.4 | +67.2 | -35.8 | -171.5 | +56.8 |
| Earnings Per Share (HKD) | 0.01 | -0.031 | -0.096 | -0.071 | -0.026 |
| Earnings Per Share Growth (%) | +130.3 | +67.2 | -35.7 | -170.5 | +58.7 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 17.47 | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | -0.018 | -0.030 | 0.000 | 0.094 | 0.168 |
| Auditors' Opinion | N/A | Qualified | Qualified | Unqualified # | Qualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 71.948 | 152.299 | -52.8 | 198.032 |
| Operating Result | 47.574 | -87.333 | -154.5 | -270.54 |
| Profit Before Taxation | 61.309 | -88.366 | -169.4 | -272.585 |
| Taxation | 0.011 | -0.326 | -103.4 | -0.016 |
| Profit /( Loss) After Taxation | 61.298 | -88.04 | -169.6 | -272.569 |
| Minority Interests | 34.499 | 0.067 | +51,391.0 | -3.63 |
| Net Profit | 26.799 | -88.107 | -130.4 | -268.939 |
| Earnings Per Share () | 0.0095 | -0.0314 | -130.3 | -0.0958 |
| Announcement Date | 2026-03-27 | 2025-03-26 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
